HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Jianbing Wu Selected Research
Jianbing Wu Research Topics
Disease
22
Neoplasms (Cancer)
03/2024 - 01/2013
21
Hepatocellular Carcinoma (Hepatoma)
05/2024 - 01/2017
5
Inflammation (Inflammations)
12/2023 - 06/2012
4
Neoplasm Metastasis (Metastasis)
12/2023 - 01/2021
3
Neuroinflammatory Diseases
12/2023 - 01/2022
3
Triple Negative Breast Neoplasms
12/2023 - 09/2018
3
Ischemic Stroke
12/2023 - 01/2022
3
Melanoma (Melanoma, Malignant)
01/2020 - 05/2017
2
Carcinogenesis
01/2023 - 01/2022
2
Hypoxia (Hypoxemia)
12/2021 - 01/2021
1
Glioma (Gliomas)
03/2024
1
Echinococcosis (Hydatid Cysts)
12/2023
1
Pancreatic Neoplasms (Pancreatic Cancer)
12/2023
1
Weight Loss (Weight Reduction)
12/2023
1
Cryptococcosis
10/2023
1
Wounds and Injuries (Trauma)
03/2023
1
Fatigue
07/2022
1
Drug-Related Side Effects and Adverse Reactions
01/2022
1
Edema (Dropsy)
01/2022
1
Cognitive Dysfunction
01/2022
1
Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome)
01/2022
1
Abdominal Pain (Pain, Abdominal)
01/2022
1
Microsatellite Instability
01/2022
1
Glaucoma
01/2022
1
Neutropenia
01/2022
1
Ocular Hypertension (Glaucoma, Suspect)
01/2022
1
Cerebral Infarction
01/2022
1
Ischemia
12/2021
Drug/Important Bio-Agent (IBA)
10
Nitric Oxide (Nitrogen Monoxide)
FDA Link
03/2024 - 10/2016
7
Sorafenib (BAY 43-9006)
FDA Link
01/2023 - 01/2015
6
Biomarkers (Surrogate Marker)
IBA
01/2023 - 01/2013
5
Immune Checkpoint Inhibitors
IBA
06/2023 - 01/2021
4
lenvatinib
IBA
05/2024 - 01/2022
4
RNA (Ribonucleic Acid)
IBA
01/2023 - 01/2021
4
Actin-Related Protein 2-3 Complex (Arp2 3 Complex)
IBA
01/2022 - 01/2021
3
Peptides (Polypeptides)
IBA
12/2023 - 09/2019
3
Nitric Oxide Donors
IBA
10/2023 - 05/2017
3
regorafenib
IBA
01/2023 - 01/2021
3
DNA (Deoxyribonucleic Acid)
IBA
01/2022 - 01/2021
2
bergaptol
IBA
03/2024 - 01/2022
2
Reducing Agents
IBA
12/2023 - 11/2020
2
Prodrugs
IBA
12/2023 - 10/2022
2
Bevacizumab (Avastin)
FDA Link
06/2023 - 01/2021
2
Biosimilar Pharmaceuticals
IBA
06/2023 - 01/2021
2
Cisplatin (Platino)
FDA Link
Generic
10/2022 - 11/2020
2
Aspartate Aminotransferases (Aspartate Transaminase)
IBA
07/2022 - 01/2022
2
Methyltransferases
IBA
01/2022 - 01/2022
2
Therapeutic Uses
IBA
01/2022 - 01/2021
2
Long Noncoding RNA
IBA
01/2022 - 01/2018
2
diazeniumdiolate
IBA
01/2018 - 10/2016
2
Proteins (Proteins, Gene)
FDA Link
01/2018 - 01/2013
2
Antineoplastic Agents (Antineoplastics)
IBA
01/2018 - 10/2016
1
Antibodies
IBA
03/2024
1
Immunoconjugates (Immunoconjugate)
IBA
03/2024
1
Cysteine (L-Cysteine)
FDA Link
03/2024
1
Platinum
IBA
12/2023
1
Harmine (Telepathine)
IBA
12/2023
1
Carbolines (Beta-Carbolines)
IBA
12/2023
1
MicroRNAs (MicroRNA)
IBA
12/2023
1
Lipopolysaccharides
IBA
12/2023
1
citral (neral)
IBA
12/2023
1
baicalin
IBA
10/2023
1
Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)
IBA
10/2023
1
echinacoside
IBA
10/2023
1
Azoles
IBA
10/2023
1
Collagen
IBA
03/2023
1
Intercellular Signaling Peptides and Proteins (Growth Factors)
IBA
03/2023
1
Chemokines
IBA
01/2023
1
Telmisartan (Micardis)
FDA Link
12/2022
1
Myelin Basic Protein
IBA
12/2022
1
isoborneol (borneol)
IBA
12/2022
1
Neurofilament Proteins
IBA
12/2022
1
Esters
IBA
12/2022
1
Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)
IBA
01/2022
1
Ligands
IBA
01/2022
1
Lysine (L-Lysine)
FDA Link
01/2022
1
Ephrin-A5 (AL-1)
IBA
01/2022
1
K-115
IBA
01/2022
1
Ephrin-B1 (Ephrin B1)
IBA
01/2022
1
Ephrin-B3 (Ephrin B3)
IBA
01/2022
1
3-n-butylphthalide (butylphthalide)
IBA
01/2022
1
Ephrin-A1 (Ephrin A1)
IBA
01/2022
1
Ephrins
IBA
01/2022
1
Neuroprotective Agents
IBA
01/2022
1
Protein Kinases (Protein Kinase)
IBA
01/2022
1
Sulfhydryl Compounds (Thiols)
IBA
12/2021
1
Oxygen (Dioxygen)
IBA
12/2021
1
Glucose (Dextrose)
FDA Link
Generic
12/2021
1
Nitrites
IBA
12/2021
1
Liposomes (Liposome)
IBA
03/2021
1
Acrolein (Aqualin)
IBA
03/2021
1
Free Radicals
IBA
03/2021
1
Paraffin
IBA
01/2021
1
sintilimab
IBA
01/2021
Therapy/Procedure
7
Therapeutics
10/2022 - 01/2015
4
Immunotherapy
03/2024 - 01/2021
3
Drug Therapy (Chemotherapy)
05/2024 - 01/2022
2
Subcutaneous Injections
01/2021 - 10/2020
1
Oral Administration
01/2022
1
Topical Administration
01/2022